Oral ketamine for children with chronic pain: a pilot phase 1 study.

ABSTRACT:

Objective

To assess whether oral ketamine is safe at higher dosages for sedating children and whether it may be an option for the control of chronic pain in children.

Study design

A prospective study was performed on 12 children with chronic pain to identify the maximum tolerated dosage of oral ketamine. Participants were given 14 days of oral ketamine, 3 times daily, at dosages ranging from 0.25-1.5 mg/kg/dose. Participants were assessed for toxicity and for pain severity at baseline and on day 14 of treatment.

Results

Two participants, both treated at 1.5 mg/kg/dose, experienced dose-limiting toxicities (sedation and anorexia). One participant, treated at 1 mg/kg/dose, opted to stop ketamine treatment due to new pain on treatment. Nine participants completed their c

SUBMITTER: Bredlau AL 

PROVIDER: S-EPMC3799772 | biostudies-literature | 2013 Jul

REPOSITORIES: biostudies-literature